Back to Search
AMISH R PUROHIT M.D.
M.D.
Ophthalmology Physician
NPI: 1346262698Individual
Specialties, Licenses & Credentials
Ophthalmology PhysicianPrimary
Ophthalmology
Code: 207W00000X
036118478(IL)MD51925(TN)
Research & Publications (20)
Development of hormone-dependent prostate cancer models for the evaluation of inhibitors of 17beta-hydroxysteroid dehydrogenase type 3.
PMID 18786604·Mol Cell Endocrinol·2009
7-preclinical
BCRP expression does not result in resistance to STX140 in vivo, despite the increased expression of BCRP in A2780 cells in vitro after long-term STX140 exposure.
PMID 19156141·Br J Cancer·2009
7-preclinical
The development of steroid sulfatase inhibitors for hormone-dependent cancer therapy.
PMID 19250195·Ann N Y Acad Sci·2009
6-review
The design of novel 17beta-hydroxysteroid dehydrogenase type 3 inhibitors.
PMID 18775469·Mol Cell Endocrinol·2009
8-other
Assessment of 18F-labeled mitochondrial complex I inhibitors as PET myocardial perfusion imaging agents in rats, rabbits, and primates.
PMID 18716773·Eur J Nucl Med Mol Imaging·2009
7-preclinical
Masitinib, a c-kit/PDGF receptor tyrosine kinase inhibitor, improves disease control in severe corticosteroid-dependent asthmatics.
PMID 19614621·Allergy·2009
3-trial
STX140 is efficacious in vitro and in vivo in taxane-resistant breast carcinoma cells.
PMID 18223236·Clin Cancer Res·2008
7-preclinical
Inhibition of steroid sulfatase activity in endometriotic implants by STX64 (667Coumate): a potential new therapy.
PMID 19112542·ScientificWorldJournal·2008
8-other
Non-steroidal aromatase inhibitors based on a biphenyl scaffold: synthesis, in vitro SAR, and molecular modelling.
PMID 18236493·ChemMedChem·2008
8-other
2-Methoxyoestradiol-3,17-O,O-bis-sulphamate and 2-deoxy-D-glucose in combination: a potential treatment for breast and prostate cancer.
PMID 18985042·Br J Cancer·2008
7-preclinical
Recent developments of steroid sulfatase inhibitors as anti-cancer agents.
PMID 18855575·Anticancer Agents Med Chem·2008
6-review
Variability of IgE reactivity profiles among European mite allergic patients.
PMID 19021722·Eur J Clin Invest·2008
7-preclinical
Synthesis of aromatase inhibitors and dual aromatase steroid sulfatase inhibitors by linking an arylsulfamate motif to 4-(4H-1,2,4-triazol-4-ylamino)benzonitrile: SAR, crystal structures, in vitro and in vivo activities.
PMID 18816537·ChemMedChem·2008
8-other
Efficacy of three potent steroid sulfatase inhibitors: pre-clinical investigations for their use in the treatment of hormone-dependent breast cancer.
PMID 17914670·Breast Cancer Res Treat·2008
7-preclinical
Effects of C-17 heterocyclic substituents on the anticancer activity of 2-ethylestra-1,3,5(10)-triene-3-O-sulfamates: synthesis, in vitro evaluation and computational modelling.
PMID 18972041·Org Biomol Chem·2008
8-other
Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis.
PMID 19000581·J Allergy Clin Immunol·2008
4-observational
Inhibition of steroid sulphatase activity in endometriotic implants by 667 COUMATE: a potential new therapy.
PMID 18056119·Hum Reprod·2008
8-other
Effects of mutations and glycosylations on STS activity: a site-directed mutagenesis study.
PMID 18180093·Mol Cell Endocrinol·2008
7-preclinical
Entomological studies for surveillance and prevention of dengue in arid and semi-arid districts of Rajasthan, India.
PMID 18592841·J Vector Borne Dis·2008
7-preclinical
Inhibition of allergen-induced wheal and flare reactions by levocetirizine and desloratadine.
PMID 17953719·Br J Clin Pharmacol·2008
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 520 RIVERGATE PARKWAY
GOODLETTSVILLE, TN 37072 - Phone
- (615) 859-3937
Quick Facts
- NPI
- 1346262698
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile